University of Florida
212 articles about University of Florida
-
Entrinsic Bioscience Shares Breakthrough in Rehydration Technology at Prestigious Plenary Session During Digestive Disease Week
5/8/2023
Groundbreaking research conducted by a team of leading researchers at Entrinsic Bioscience and the University of Florida revealed significant findings that will change the way we understand amino acid combinations and represents the next generation of Oral Rehydration Solutions.
-
Cancer research facilities are leading the way with methods that will lead to better detection of cancer metastasis, better understanding of cancer cell physiology and greater patient response.
-
Deaths from drug overdoses have been on an upward trajectory for years, but have experienced a notable increase since the early days of the COVID-19 pandemic.
-
AavantiBio Furthers Strategic Partnership with University of Florida to Research and Develop Next Generation Gene Therapy Capsids
10/12/2021
AavantiBio today announced it is partnering with the University of Florida to research and develop next generation gene therapy capsids with the goal of creating safer, more effective, and tissue specific gene therapies.
-
Parent Project Muscular Dystrophy Awards $348,891 Grant to University of Florida Wellstone Center
3/3/2021
Grant Will Provide Bridge Funding for Dr. H Lee Sweeney's Research to Understand and Improve Gene Therapy in Duchenne
-
New Program in Pharmaceutical Value Assessment and Communications Launched by University of Florida College of Pharmacy Online Graduate Program
1/21/2021
The University of Florida College of Pharmacy’s online graduate program in pharmaceutical outcomes and policy announced the launch of a new track, Pharmaceutical Value Assessment and Communications.
-
Decibel Therapeutics Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology
11/2/2020
Decibel Therapeutics , a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, today announced exclusive license agreements with the University of Florida (UF) and the University of California, San Francisco (UCSF) for an adeno-associated virus (AAV) gene therapy technology designed to restore hearing to individuals with profound, congenital hearing loss c
-
BridgeBio Pharma and University of Florida Establish Collaboration to Advance Therapies for Genetically Driven Diseases
6/18/2020
Partnership to Leverage University of Florida’s Research in Gene Therapy and BridgeBio’s Translational Expertise in Rare and Genetic Disease
-
Trualta and University of Florida study evaluates impact of family caregiver education
2/4/2020
Goal is to equip families with the skills to help loved ones age in place
-
Immunomic Therapeutics Assumes Sponsorship of ATTAC-II IND for ITI-1000, a Dendritic Cell Vaccine in Phase 2 for the Treatment of GBM
10/1/2019
ITI-1000 targets CMV with Immunomic Therapeutics’ immunotherapy UNITE™ platform
-
Scientists Eye Novel Drug Candidate With Marine Origins To Treat Vision Loss
8/8/2019
Researchers from Singapore and the United States are focused on a novel drug candidate with marine origins as a new method to prevent or treat vision loss.
-
Medical Device Company MLM Biologics Graduates from UF Innovate | Sid Martin Biotech Program
5/28/2019
The company is commercializing its FDA-cleared bio-ConneKt® Wound Matrix to the advance wound care market.
-
Research Roundup: Gene Therapy for Deafness, Autism Genes, Breakthroughs in Parkinson’s and ALS, ...
3/1/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
JDRF, ADA and Helmsley Charitable Trust Announce Funding of Quantitative Analysis of Insulin Purchased from Pharmacies in the U.S.
10/11/2018
JDRF International, the American Diabetes Association (ADA) and The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley) together announce the awarding of funding to the University of Florida for a one-year investigation by Dr. Timothy Garrett of the consistency and potency of insulin that is purchased at retail pharmacies across the United States.
-
Hyundai Hope On Wheels Presents University Of Florida Health Shands Children's Hospital With $200,000 Young Investigator Grant To Support Pediatric Cancer Research
9/18/2018
The Hyundai Hope On Wheels Foundation embarks on a nationwide tour this September in honor of National Childhood Cancer Awareness Month to award $14.1 million to 38 researchers, surpassing $145 million in total giving.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Cambridge, Mass.-based Sarepta Therapeutics expanded its gene therapy pipeline up to 11 in an equity deal with Lacerta Therapeutics. Investing $30 million into Alachua, Florida-based Lacerta Therapeutics, Sarepta gained access to the company’s AAV-based CNS-targeted gene therapies.
-
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development
10/31/2017
The research will be conducted at a laboratory at the University of Florida's McKnight Brain Institute focused on neurotrauma, neuroproteomics and biomarkers research headed by Wang.
-
CRISPR And Collaborators At The University of Florida Awarded Target ALS Grant To Develop CRISPR/Cas9-Based Approaches For ALS
5/16/2017
-
Liquid Silicone 3D Printing Is Designed For Faster And Cheaper Medical Implants, University of Florida Reveals
5/12/2017